LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 89.97 | 21.74 | 1156 | 6084 | 0.1900 | 0.6304 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 89.97 | 21.74 | 11672 | 6084 | 1.9183 | 1.1669 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 91.94 | 21.74 | 2453 | 6121 | 0.4007 | 0.7874 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 91.94 | 21.74 | 14914 | 6121 | 2.4362 | 1.2313 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 91.94 | 21.74 | 209 | 6121 | 0.0341 | 0.3206 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 91.94 | 21.74 | 11624 | 6121 | 1.8988 | 1.1640 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 93.92 | 21.74 | 1386 | 6070 | 0.2283 | 0.6676 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 93.92 | 21.74 | 15169 | 6070 | 2.4990 | 1.2386 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 93.92 | 21.74 | 30 | 6070 | 0.0049 | 0.0404 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 93.92 | 21.74 | 11606 | 6070 | 1.9120 | 1.1661 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.24 | 21.74 | 563 | 183 | 3.0669 | 1.8784 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.24 | 21.74 | 419 | 183 | 2.2825 | 1.6150 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.24 | 21.74 | 665 | 317 | 2.0926 | 1.4205 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.24 | 21.74 | 616 | 317 | 1.9384 | 1.3731 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.21 | 21.74 | 6 | 392 | 0.0153 | -0.2655 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.21 | 21.74 | 749 | 392 | 1.9107 | 1.3357 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.21 | 21.74 | 721 | 392 | 1.8393 | 1.3145 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 8.19 | 21.74 | 8 | 439 | 0.0182 | -0.2058 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 8.19 | 21.74 | 819 | 439 | 1.8620 | 1.3081 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | D12 |